Avacta Group Management
Management criteria checks 2/4
Avacta Group's CEO is David Alastair Smith, appointed in Jan 2005, has a tenure of 19.33 years. total yearly compensation is £444.00K, comprised of 64.4% salary and 35.6% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth £196.15K. The average tenure of the management team and the board of directors is 2.7 years and 2.8 years respectively.
Key information
David Alastair Smith
Chief executive officer
UK£444.0k
Total compensation
CEO salary percentage | 64.4% |
CEO tenure | 19.3yrs |
CEO ownership | 0.1% |
Management average tenure | 2.7yrs |
Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Investors Give Avacta Group Plc (LON:AVCT) Shares A 26% Hiding
Feb 23Getting In Cheap On Avacta Group Plc (LON:AVCT) Is Unlikely
Aug 05Would Avacta Group (LON:AVCT) Be Better Off With Less Debt?
Jun 22We're Hopeful That Avacta Group (LON:AVCT) Will Use Its Cash Wisely
Oct 20This Is The Reason Why We Think Avacta Group Plc's (LON:AVCT) CEO Deserves A Bump Up To Their Compensation
Jun 22Avacta Group (LON:AVCT) Is In A Good Position To Deliver On Growth Plans
Jun 20Avacta Group Plc (LON:AVCT) Insiders Have Been Selling
Feb 18Companies Like Avacta Group (LON:AVCT) Are In A Position To Invest In Growth
Jan 23What Kind Of Shareholders Hold The Majority In Avacta Group Plc's (LON:AVCT) Shares?
Dec 27How Is Avacta Group's (LON:AVCT) CEO Paid Relative To Peers?
Dec 06CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -UK£25m |
Sep 30 2023 | n/a | n/a | -UK£34m |
Jun 30 2023 | n/a | n/a | -UK£42m |
Mar 31 2023 | n/a | n/a | -UK£41m |
Dec 31 2022 | UK£444k | UK£286k | -UK£40m |
Sep 30 2022 | n/a | n/a | -UK£32m |
Jun 30 2022 | n/a | n/a | -UK£25m |
Mar 31 2022 | n/a | n/a | -UK£26m |
Dec 31 2021 | UK£418k | UK£275k | -UK£26m |
Jun 30 2021 | n/a | n/a | -UK£20m |
Mar 31 2021 | n/a | n/a | -UK£18m |
Dec 31 2020 | UK£275k | UK£237k | -UK£16m |
Jun 30 2020 | n/a | n/a | -UK£12m |
Mar 31 2020 | n/a | n/a | -UK£12m |
Dec 31 2019 | UK£328k | UK£282k | -UK£11m |
Jul 31 2019 | n/a | n/a | -UK£10m |
Apr 30 2019 | n/a | n/a | -UK£10m |
Jan 31 2019 | n/a | n/a | -UK£10m |
Oct 31 2018 | n/a | n/a | -UK£9m |
Jul 31 2018 | UK£208k | UK£193k | -UK£9m |
Apr 30 2018 | n/a | n/a | -UK£8m |
Jan 31 2018 | n/a | n/a | -UK£7m |
Oct 31 2017 | n/a | n/a | -UK£7m |
Jul 31 2017 | UK£201k | UK£188k | -UK£6m |
Compensation vs Market: David Alastair's total compensation ($USD557.15K) is about average for companies of similar size in the UK market ($USD772.87K).
Compensation vs Earnings: David Alastair's compensation has increased whilst the company is unprofitable.
CEO
David Alastair Smith (57 yo)
19.3yrs
Tenure
UK£444,000
Compensation
Dr. David Alastair Maclaughlin Smith co-founded Avacta Group Plc in January 2004 and has been its Chief Executive Officer since 2005. Dr. Smith is a Professor of Molecular Biophysics, Head of the Molecular...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 19.3yrs | UK£444.00k | 0.12% £ 196.1k | |
CFO, Company Secretary & Executive Director | 8.3yrs | UK£273.00k | 0.0023% £ 3.7k | |
Head of Research & Development | less than a year | UK£37.00k | no data | |
Group In-House Counsel | no data | no data | no data | |
Group Communications Director | 3.3yrs | no data | no data | |
Chief Operating Officer of Diagnostics | 7.8yrs | UK£69.00k | no data | |
Chief Scientific Officer of Diagnostics | 3.3yrs | no data | no data | |
Chief Scientific Officer of Therapeutics Division | 2.7yrs | no data | no data | |
Chief Commercial Officer of Diagnostics | 1.3yrs | no data | no data | |
Chief Operating Officer of Therapeutics Division | 1.2yrs | no data | no data | |
Joint Managing Director of Launch Diagnostics | 1.1yrs | no data | no data | |
Joint Managing Director of Launch Diagnostics | 1.1yrs | no data | no data |
2.7yrs
Average Tenure
53yo
Average Age
Experienced Management: AVCT's management team is considered experienced (2.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 16.7yrs | UK£444.00k | 0.12% £ 196.1k | |
CFO, Company Secretary & Executive Director | 8.3yrs | UK£273.00k | 0.0023% £ 3.7k | |
Head of Research & Development | 2.2yrs | UK£37.00k | no data | |
Independent Non-Executive Director | 10.8yrs | UK£40.00k | 0.030% £ 48.9k | |
Independent Non-Executive Chairman | 5.9yrs | UK£100.00k | 0.048% £ 77.2k | |
Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | 2.8yrs | UK£45.00k | no data | |
Independent Non-Executive Director | 4.3yrs | UK£40.00k | no data | |
Member of Scientific Advisory Board | 2.7yrs | no data | no data | |
Member of Scientific Advisory Board | 2.7yrs | no data | no data | |
Member of Scientific Advisory Board | 2.7yrs | no data | no data |
2.8yrs
Average Tenure
57yo
Average Age
Experienced Board: AVCT's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.